FAKHRAVAC
id:
fakhravac-317-11008210
title:
FAKHRAVAC
text:
FAKHRAVAC is a COVID-19 vaccine developed in Iran by the Organization of Defensive Innovation and Research, a subsidiary of Iran's Ministry of Defense. It is the third Iranian COVID-19 vaccine reaching clinical trials. It is currently in phase III. It received emergency use authorization in Iran on 9 September 2021. The vaccine is named after the Iranian nuclear scientist Mohsen Fakhrizadeh. According to the Iranian authorities, he was working on a vaccine in response to the COVID-19 pandemic in
brand slug:
wiki
category slug:
encyclopedia
description:
Vaccine against COVID-19
original url:
https://en.wikipedia.org/wiki/FAKHRAVAC
date created:
date modified:
2024-03-27T05:29:22Z
main entity:
{"identifier":"Q107366045","url":"https://www.wikidata.org/entity/Q107366045"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/94/Coronavirus._SARS-CoV-2.png","width":2048,"height":2048}
fields total:
13
integrity:
15